Peer Review History: Fixed-Dose Combination of Dipeptidyl Peptidase-4 Inhibitors Plus Metformin in Patients with Type 2 Diabetes: A Review on Safety and Efficacy

Editor(s):

(1) Dr. Koteshwara Mudigonda, Propharmex Company, India.

Reviewers:

(1) Manal Khalid Abdulridha, Mustansiriyah University, Iraq.

(2) Ignacio Rodríguez-Rodríguez, Universidad de Málaga, Spain.

Additional Reviewers:

 

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.75/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Manal Khalid Abdulridha, Iraq) | File 1 | NA


Stage 2 | Peer review report_2 (Ignacio Rodríguez-Rodríguez, Spain) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


 

Posted in Review History.